BioCentury | May 11, 2018
Financial News

AxoGen raises $123M in upsized follow-on

...million shares. AxoGen markets a portfolio of products for peripheral nervous system repair, including the AVANCE...
BioCentury | May 9, 2018
Financial News

AxoGen raises $123M in upsized follow-on

...million shares. AxoGen markets a portfolio of products for peripheral nervous system repair, including the AVANCE...
BioCentury | Aug 12, 2013
Finance

Highlights of weekly biotech stock moves

...through the sale of 6 million shares at $3 in a follow-on. AxoGen markets the Avance...
BioCentury | Aug 9, 2013
Financial News

AxoGen, Tonix raise money in follow-ons, list on NASDAQ

...a share at $4.25. AxoGen markets products designed to protect or connect nerves, including its Avance...
BioCentury | Oct 15, 2012
Company News

AxoGen Inc., PDL BioPharma deal

...in years five through eight. AxoGen's marketed surgical solutions for peripheral nerve repair include its Avance...
BioCentury | Jul 23, 2012
Company News

AxoGen Inc. sales and marketing update

...AxoGen said partner MD for Life S.r.l. (Catania, Italy) launched Avance Nerve Graft for bridging nerve...
BioCentury | Mar 16, 2009
Clinical News

AVANCE Nerve Graft neurology data

...Data from 9 patients with digital nerve injuries showed that AVANCE Nerve Graft restored nerve sensation...
...the product in 2007 to repair peripheral nerve damage. AxoGen Inc. , Alachua, Fla. Product: AVANCE...
BioCentury | Sep 3, 2007
Company News

Bruker BioSciences Corp. sales and marketing update

...BRKR launched its Avance III NanoBay NMR spectrometer. Bruker BioSciences Corp. (BRKR), Billerica, Mass. Business: Supply/Service WIR...
BioCentury | Apr 12, 2004
Company News

Avance management update

Avance Pharma Inc. , Laval, Quebec Business: Infectious, Cancer Hired: Bahige Baroudy as VP of drug discovery, formerly group director of antiviral and antimicrobial therapy at Schering-Plough Research Institute WIR Staff...
BioCentury | Apr 21, 2003
Company News

Achillion, Phytobiotech deal

...The companies partnered to discover compounds active against infectious disease targets. Phytobiotech will supply Achillion with...
...companies will jointly develop any resulting drug candidates. Achillion Pharmaceuticals Inc. , New Haven, Conn. Phytobiotech...
Items per page:
1 - 10 of 14
BioCentury | May 11, 2018
Financial News

AxoGen raises $123M in upsized follow-on

...million shares. AxoGen markets a portfolio of products for peripheral nervous system repair, including the AVANCE...
BioCentury | May 9, 2018
Financial News

AxoGen raises $123M in upsized follow-on

...million shares. AxoGen markets a portfolio of products for peripheral nervous system repair, including the AVANCE...
BioCentury | Aug 12, 2013
Finance

Highlights of weekly biotech stock moves

...through the sale of 6 million shares at $3 in a follow-on. AxoGen markets the Avance...
BioCentury | Aug 9, 2013
Financial News

AxoGen, Tonix raise money in follow-ons, list on NASDAQ

...a share at $4.25. AxoGen markets products designed to protect or connect nerves, including its Avance...
BioCentury | Oct 15, 2012
Company News

AxoGen Inc., PDL BioPharma deal

...in years five through eight. AxoGen's marketed surgical solutions for peripheral nerve repair include its Avance...
BioCentury | Jul 23, 2012
Company News

AxoGen Inc. sales and marketing update

...AxoGen said partner MD for Life S.r.l. (Catania, Italy) launched Avance Nerve Graft for bridging nerve...
BioCentury | Mar 16, 2009
Clinical News

AVANCE Nerve Graft neurology data

...Data from 9 patients with digital nerve injuries showed that AVANCE Nerve Graft restored nerve sensation...
...the product in 2007 to repair peripheral nerve damage. AxoGen Inc. , Alachua, Fla. Product: AVANCE...
BioCentury | Sep 3, 2007
Company News

Bruker BioSciences Corp. sales and marketing update

...BRKR launched its Avance III NanoBay NMR spectrometer. Bruker BioSciences Corp. (BRKR), Billerica, Mass. Business: Supply/Service WIR...
BioCentury | Apr 12, 2004
Company News

Avance management update

Avance Pharma Inc. , Laval, Quebec Business: Infectious, Cancer Hired: Bahige Baroudy as VP of drug discovery, formerly group director of antiviral and antimicrobial therapy at Schering-Plough Research Institute WIR Staff...
BioCentury | Apr 21, 2003
Company News

Achillion, Phytobiotech deal

...The companies partnered to discover compounds active against infectious disease targets. Phytobiotech will supply Achillion with...
...companies will jointly develop any resulting drug candidates. Achillion Pharmaceuticals Inc. , New Haven, Conn. Phytobiotech...
Items per page:
1 - 10 of 14